| | |
| 4.1 | — | Supplemental Indenture No. 54, dated as of April 30, 2026, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on April 30, 2026, and incorporated herein by reference). |
| | |
| 4.2 | — | Supplemental Indenture No. 55, dated as of April 30, 2026, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed on April 30, 2026, and incorporated herein by reference). |
| | |
| 4.3 | — | Supplemental Indenture No. 56, dated as of April 30, 2026, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on April 30, 2026, and incorporated herein by reference). |
| | |
| 4.4 | — | Form of 4.700% Senior Notes due 2031 (included in Exhibit 4.1). |
| | |
| 4.5 | — | Form of 5.000% Senior Notes due 2033 (included in Exhibit 4.2). |
| | |
| 4.6 | — | Form of 5.300% Senior Notes due 2036 (included in Exhibit 4.3). |
| | |
| 22 | — | List of Subsidiary Guarantors and Pledged Securities. |
| | |
| 31.1 | — | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | |
| 31.2 | — | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | |
| 32 | — | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| | |
| 101 | — | The following financial information from our quarterly report on Form 10-Q for the quarter ended June 30, 2026 filed with the SEC on July 28, 2026, formatted in Inline Extensible Business Reporting Language: (i) the condensed consolidated balance sheets at June 30, 2026 and December 31, 2025, (ii) the condensed consolidated income statements for the quarters and six months ended June 30, 2026 and 2025, (iii) the condensed consolidated comprehensive income statements for the quarters and six months ended June 30, 2026 and 2025, (iv) the condensed consolidated statements of stockholders’ equity (deficit) for the quarters and six months ended June 30, 2026 and 2025, (v) the condensed consolidated statements of cash flows for the six months ended June 30, 2026 and 2025 and (vi) the notes to condensed consolidated financial statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| | |
| 104 | — | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, formatted in Inline XBRL (included in Exhibit 101). |
filings.tools